These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Preliminary results from ...
News
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of ...
- Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with ...
... San Antonio Breast Cancer Symposium (SABCS 2024) being held December 10-13 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
- Bio-Techne Corp (TECH) Launches Innovative ESR1 Mutation Monitoring Assay
The assay will be featured at the San Antonio Breast Cancer Symposium, offering a highly sensitive detection method using qPCR technology. This ...
- BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer
The German biotech ... Researchers shared the first look at OS data from the Chinese trial at the San Antonio Breast Cancer Symposium Tuesday.
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with ... - Morningstar
Data from Phase 1b/2 clinical trial to be presented at 2024 San Antonio Breast Cancer Symposium (SABCS) show encouraging clinical activity in ...